Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose
Clinical trial NCT01327066 · COMPLETED
Trial details
- NCT number
- NCT01327066
- Sponsor
- Chelsea Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-04-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.